Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer
| Image |  |
|---|---|
| Description | scientific article published on 22 February 2019 |
| Author/s |
author: Chuan Xu Shengxiang Ren Caicun Zhou |
| Publication date | February 22, 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |